Innate lymphoid cells (ILCs), a critical component of the immune system, have recently been
nominated as emerging players associated with tumor progression and inhibition. ILCs are …

Simple Summary The emergence of immunotherapy for cancer treatment bears
considerable clinical promise. The role of NK cells in tumor immunosurveillance and their …

In the last decade, immune therapies against human cancers have emerged as a very
effective therapeutic strategy in the treatment of various cancers, some of which are resistant …

Innate lymphoid cells (ILCs)–which include cytotoxic Natural Killer (NK) cells and helper-
type ILC–are important regulators of tissue immune homeostasis, with possible roles in …

NK cells and tissue-resident innate lymphoid cells (ILCs) are innate effectors found in the
skin. To investigate their temporal dynamics and specific functions throughout the …

Since their relatively recent discovery, innate lymphoid cells (ILCs) have been shown to be
tissue-resident lymphocytes that are critical mediators of tissue homeostasis, regeneration …

The treatment landscape in oncology has witnessed a major revolution with the introduction
of checkpoint inhibitors: anti-PD1, anti-PDL1 and anti-CTLA-4. These agents enhance the …

Innate lymphoid cells (ILCs) are largely tissue resident and respond rapidly toward the
environmental signals from surrounding tissues and other immune cells. The pleiotropic …

Abstract Innate Lymphoid Cells (ILCs) are a recently described heterogeneous population of
non-T, non-B lymphocytes. They are highly abundant at mucosal interfaces and, unlike T …

Advances in immunotherapy against advanced cancers can be considered stunning and
epoch‐making. Meanwhile, efficacy of immune‐based therapies, especially immune …